Cite
MLA Citation
Tanguy Y. Seiwert et al.. “A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab‐resistant head and neck cancer: The MAESTRO study.” Cancer, vol. 126, no. 14, 2020, pp. 3237–3243. http://access.bl.uk/ark:/81055/vdc_100103802637.0x000060